133 related articles for article (PubMed ID: 35989896)
1. Hepatic steatosis as measured by the computed attenuation parameter predicts fibrosis in long-term methotrexate use.
Tomaszewski M; Dahiya M; Mohajerani SA; Punja H; Ko HH; Sun M; Ramji A
Can Liver J; 2021; 4(4):370-380. PubMed ID: 35989896
[TBL] [Abstract][Full Text] [Related]
2. Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index.
Castiella A; Lopez-Dominguez L; Sanchez-Iturri MJ; Urreta I; De Diego A; Belzunegui J; Zapata E
World J Hepatol; 2023 May; 15(5):699-706. PubMed ID: 37305368
[TBL] [Abstract][Full Text] [Related]
3. Use of transient elastography to assess hepatic steatosis and fibrosis in patients with juvenile idiopathic arthritis during methotrexate treatment.
Niyasom C; Soponkanaporn S; Vilaiyuk S; Lertudomphonwanit C; Getsuwan S; Tanpawpong P; Kaewduang P; Sobhonslidsuk A
Clin Rheumatol; 2024 Jan; 43(1):423-433. PubMed ID: 38062311
[TBL] [Abstract][Full Text] [Related]
4. Liver Involvement in Patients with Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis.
Cuomo G; Iandoli C; Galiero R; Caturano A; Di Vico C; Perretta D; Adamo PV; Ferrara R; Rinaldi L; Romano C; Sasso FC
Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238250
[No Abstract] [Full Text] [Related]
5. Ultrasound liver elastography for the detection of liver fibrosis in patients with psoriasis and reactive arthritis on long-term methotrexate therapy: A cross-sectional study.
Khandpur S; Yadav D; Jangid B; Kumar A; Shalimar ; Devasenathipathy K; Sharma R; Gupta SD; Kumar R; Kalaivani M
Indian J Dermatol Venereol Leprol; 2020; 86(5):508-514. PubMed ID: 32525101
[TBL] [Abstract][Full Text] [Related]
6. Screening for hepatic fibrosis and steatosis in Turkish patients with type 2 diabetes mellitus: A transient elastography study.
Demir M; Deyneli O; Yılmaz Y
Turk J Gastroenterol; 2019 Mar; 30(3):266-270. PubMed ID: 30411703
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with controlled attenuation parameter (CAP).
Cardoso AC; Perez RM; de Figueiredo-Mendes C; Carvalho Leite N; Moraes-Coelho HS; Villela-Nogueira CA
J Viral Hepat; 2018 Nov; 25(11):1244-1250. PubMed ID: 29768686
[TBL] [Abstract][Full Text] [Related]
8. Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients.
Rout G; Kedia S; Nayak B; Yadav R; Das P; Acharya SK; Gunjan D; Singh V; Mahanta M; Gupta S; Aggarwal S; Shalimar
J Clin Exp Hepatol; 2019; 9(1):13-21. PubMed ID: 30765934
[TBL] [Abstract][Full Text] [Related]
9. Utility and Limitations of Transient Elastography to Monitor Hepatic Steatosis, Hepatic Fibrosis, and Methotrexate-Associated Hepatic Disease in Psoriasis: A Systematic Review.
Marsh RL; Kelly S; Mumtaz K; Kaffenberger J
J Clin Aesthet Dermatol; 2021 Dec; 14(12):24-28. PubMed ID: 35096251
[TBL] [Abstract][Full Text] [Related]
10. Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.
Seto WK; Hui RWH; Mak LY; Fung J; Cheung KS; Liu KSH; Wong DK; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):575-583.e2. PubMed ID: 28970146
[TBL] [Abstract][Full Text] [Related]
11. Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.
Rout G; Nayak B; Patel AH; Gunjan D; Singh V; Kedia S; Shalimar
J Clin Exp Hepatol; 2019; 9(2):207-214. PubMed ID: 31024203
[TBL] [Abstract][Full Text] [Related]
12. Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis.
Shen F; Mi YQ; Xu L; Liu YG; Wang XY; Pan Q; Zhang RN; Hu XQ; Xu LM; Fan JG
Aliment Pharmacol Ther; 2019 Jul; 50(1):93-102. PubMed ID: 31094016
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Controlled Attenuation Parameter for Detecting Hepatic Steatosis in Patients with Chronic Liver Disease.
Andrade P; Rodrigues S; Rodrigues-Pinto E; Gaspar R; Lopes J; Lopes S; Macedo G
GE Port J Gastroenterol; 2017 Jul; 24(4):161-168. PubMed ID: 29255745
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive characterization of graft steatosis after liver transplantation.
Karlas T; Kollmeier J; Böhm S; Müller J; Kovacs P; Tröltzsch M; Weimann A; Bartels M; Rosendahl J; Mössner J; Berg T; Keim V; Wiegand J
Scand J Gastroenterol; 2015 Feb; 50(2):224-32. PubMed ID: 25429378
[TBL] [Abstract][Full Text] [Related]
15. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
[TBL] [Abstract][Full Text] [Related]
16. How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
Trowell J; Alukal J; Zhang T; Liu L; Maheshwari A; Yoo HY; Thuluvath PJ
Dig Dis Sci; 2021 Apr; 66(4):1297-1305. PubMed ID: 32337667
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Steatosis in Chronic Hepatitis B as Measured by Controlled Attenuation Parameter: Frequency and Distribution.
Nan S; Liang Y; Qu Y; Liu F; Wang L; Li T
J Coll Physicians Surg Pak; 2019 Oct; 29(10):937-941. PubMed ID: 31564265
[TBL] [Abstract][Full Text] [Related]
18. Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience.
Sporea I; Mare R; Popescu A; Nistorescu S; Baldea V; Sirli R; Braha A; Sima A; Timar R; Lupusoru R
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268517
[TBL] [Abstract][Full Text] [Related]
19. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
20. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students.
Nastasa R; Stanciu C; Zenovia S; Singeap AM; Cojocariu C; Sfarti C; Girleanu I; Chiriac S; Cuciureanu T; Huiban L; Muzica CM; Trifan A
Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
